BioSpace News Archive

The evidence is clear that the COVID-19 pandemic has contributed to a worsening of the overdose crisis, which continues to affect individuals, families and communities across Canada every single day.

IntelGenx Technologies Corp., a leader in pharmaceutical films, announced that it will release its fourth quarter and full year 2021 financial results after market close on Thursday, March 24, 2022.

Perrigo Company plc (NYSE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it has received final approval from the U.S. Food and Drug Administration for the over-the-counter use of Nasonex® 24HR Allergy (mometasone furoate monohydrate 50mcg).

Liminal BioSciences Inc. (Nasdaq: LMNL) (“Liminal BioSciences” or the “Company”), today reported its financial results for the fourth quarter and year ended December 31, 2021.

Marker Therapeutics, Inc. (Nasdaq:MRKR), today provided a corporate update and reported financial results for the fiscal year ended December 31, 2021.

Albany NY, United States: Transparency Market Research has published a new report titled “Macular degeneration treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.” According to the report, the global macular degeneration treatment market was valued at US$ 6.1 Bn in 2017.

Albany NY, United States: According to the new research report by Transparency Market Research, the global airway management devices market was initially valued at US$832 mn back in 2017.

Albany NY, United States: The global foot orthotic insoles market is expanding at a rapid pace due rise in percentage of population requiring orthopedic devices to reduce foot pain and increase in geriatric population with orthotic condition across the globe.

Albany NY, United States: Transparency Market Research has published a new report titled, “Acute Lymphoblastic Leukemia Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Albany NY, United States: The global rheumatoid arthritis drugs market was valued at US$ 19597.4 Mn in 2016.